Current ABU president explains strategies to adapt training and continuing education.
Enhanced-recovery protocol leads to dramatic reduction across perioperative care.
Researchers instruct laboratory kidney cells to perform like in vivo cells.
Exploring self-management therapies, other integrative approaches.
New findings on genomic variations underlying familial prostate cancer.
1 / 5
Update from landmark CEASAR trial compares treatments at five years.
Focal therapy promises an effective, less aggressive intervention for the right patients.
Review helps clarify heart risks of prostate cancer therapies.